Results 81 to 90 of about 3,630,045 (162)
Maha S Al-Keilani,1 Dua H Alsmadi,1 Ruba S Darweesh,2 Karem H Alzoubi1 1Department of Clinical Pharmacy, College of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Pharmaceutical Technology, College of Pharmacy ...
Darweesh RS +7 more
core +1 more source
Combination chemotherapy for metastatic colorectal cancer [PDF]
Koehne Claus-Henning
doaj +1 more source
The impact of antineoplastic drugs on the intestinal microflora was studied in 9 patients with acute leukaemia during chemotherapy and in 5 patients also during chemotherapy-induced neutropenia.
Nord, Carl Erik +15 more
core +1 more source
Management of Patients Undergoing Radiation and Chemotherapy
This chapter describes the types of tumor and the criteria for treating them with radiation therapy alone, radiation therapy combined with surgery, radiation therapy combined with chemotherapy, and radiation therapy combined with both chemotherapy and ...
Kjeller, Göran,
core
Study on the sensitivity of primary glioma cell to chemotherapeutic agents in vitro
Objective To study the sensitivity of primary human glioma cell to chemotherapeutic agents in vitro in order to provide an experimental basis for clinical chemotherapy of glioma.
Ning WANG +6 more
doaj
Research advances on chemotherapy and targeted therapy of pediatric - type low - grade glioma
Pediatric - type low - grade glioma (pLGG) is the most common central nervous system tumor in children, and most pLGG exhibits non -invasive clinical behavior with a good prognosis. Total surgical resection is an important prognostic factor, and patients
GE Jing-jing +3 more
doaj +1 more source
Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort
Introduction The risk of premature ovarian insufficiency (POI) after Hodgkin's lymphoma depends on female age, type, and dose of gonadotoxic treatment.
Lotte Berdiin Colmorn +4 more
doaj +1 more source
Novel treatments, including stereotactic body radiotherapy (SBRT), targeted therapies, and immune checkpoint inhibitors (ICIs), have improved the prognosis and outcomes of patients with metastatic lung cancer.
Reyhaneh Bayani +3 more
doaj +1 more source
Background and objective Docetaxel is an active agent in the second-line treatment for non-small cell lung cancer (NSCLC), many clinical trials have demonstrated that it has similar efficacy to common first-line regimens for NSCLC. A randomized study was
Haiyong WANG +7 more
doaj
Chemotherapy (CT) is a systemic treatment using a combination of antineoplastic drugs, orally or intravenously, that inhibit tumor growth and fast-growing normal cells.
Fontes-Borges, Marcela Maria +7 more
core +1 more source

